Mesoblast Ltd - Company Profile

Powered by

All the sales intelligence you need on Mesoblast Ltd in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Mesoblast Ltd fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Mesoblast Ltd.

Back to companies

Mesoblast Ltd: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Mesoblast Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Mesoblast Ltd's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Silviu Itescu

Chief Executive Officer; Director; Managing Director Executive Board Since: 2011

Mr. Silviu Itescu has been the Chief Executive Officer, Managing Director, and Director of the company since 2011. Prior to this, he served as the Executive Director of the company from 2007.

Read Hide full bio of Silviu Itescu

Eric Rose, MD

Chief Medical Officer; Director Executive Board Since: 2022

Mr. Eric Rose has been the Chief Medical Officer and Director of the company since 2022. Prior to this, he served as the Chairman of Columbia University’s Department of Surgery and Surgeon-in-Chief of Columbia Presbyterian Medical Center in New York. Mr. Rose also served as the Chairman and Chief Executive Officer of SIGA Technologies.

Read Hide full bio of Eric Rose, MD

James M. O’Brien

Chief Financial Officer Senior Management Since: 2025

Mr. James M. O’Brien has been the Chief Financial Officer of the company since November 2025. Prior to this, he served as the Chief Financial Officer at Faron Pharmaceuticals. Earlier he held senior positions at Enzo Biochem, Actavis PLC, Nycomed Inc., and Bristol Myers Squibb.

Read Hide full bio of James M. O’Brien

Philip J. Facchina

Chairman Non Executive Board Since: 2026

Mr. Philip Facchina has been the Chairman of the company since January 2026 and Director of the company since March 2021.

Read Hide full bio of Philip J. Facchina

Geraldine Storton

Head - Regulatory Affairs and Quality Management Senior Management Since: 2015
Gain a 360-degree view of Mesoblast Ltd and make more informed decisions for your business Gain a 360-degree view of Mesoblast Ltd and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer